Today is Tuesday, July 7, 2026.

The Early Bird Index today is 89.13.

New to this newsletter? Sign up here

Rivian Automotive $RIVN ( ▲ 8.11% ) fell 9.3% in after-hours trading on Monday, as revenue growth was overshadowed by a share dilution concern.

Financials: Rivian now expects revenue to be between $1.55 billion and $1.65 billion in the second quarter, up from $1.30 billion last year. The company attributed the growth to lower average selling prices.

Details: The problem with Rivian was that the company also announced a new public offering of 75 million shares of common stock, with the proceeds being used for general corporate purposes.

Powering the Story: Investors are concerned that the additional share offering is a dilution event.

Early Bird’s Nest Egg Gains: The 75 million-share offering is a near-term supply overhang, so the stock reaction makes sense; but it does not automatically change Rivian’s longer-term operating outlook.

Final Thoughts: Rivian’s stock was up just 3.76% this year before Monday’s announcement.

OpenAI and Anthropic could be two of the biggest AI IPOs Wall Street has seen in years.

But investors don’t have to wait for those names to hit the public markets to get exposure to the AI boom.

MarketBeat’s 7 AI Stocks to Buy Now report reveals 7 publicly traded companies already positioned to benefit as the next wave of AI investment moves beyond the private model providers.

These are the stocks investors can buy today, before the IPO crowd rushes in.

See the 7 stocks

Notable Earnings Today: Penguin Solutions (Nasdaq: PENG), Enerpac Tool Group (NYSE: EPAC), Kura Sushi USA (Nasdaq: KRUS), Saratoga Investment (NYSE: SAR).

Notable IPOs Today: Alpex Acquisition Corporation Class A Ordinary Shares (Nasdaq: ALPX), Bleichroeder Acquisition Corp. III Units (Nasdaq: BCCQU), FortuneX Acquisition Corporation Ordinary Shares (Nasdaq: FXAC).

Notable Equity Crowdfunding Campaigns Ending Today: CliqRex (Netcapital), Anodos Labs (Republic), Sojourner Mobile Coffee (Honeycomb).

Notable Economic Events Today: ADP Employment Change Weekly (8:15 a.m. ET), Trade Balance / Imports / Exports (8:30 a.m. ET), NY Fed 1-Year Consumer Inflation Expectations (11:00 a.m. ET), EIA Short-Term Energy Outlook (12:00 p.m. ET), API Weekly Crude Oil Stock (4:30 p.m. ET). 

AbbVie’s $ABBV ( ▼ 2.42% ) positive momentum took a little hit when the pharmaceutical company updated its fiscal outlook on Monday after a good run in June.

Financials: The company now said in its upcoming results that it expects to include pre-tax acquired in-process research and development and milestone expenses of $291 million, which will cause earnings to fall by 17 cents per share.

Powering the Story: The $291 million was likely triggered by AbbVie’s June 2026 license acquisition activity. For example, in the previous quarter, the company had a $650 million upfront payment involving a previous acquisition. In the same way, this new charge was not an operating expense from sales or manufacturing; it was a deal-related upfront payment tied to a biotech licensing transaction.

Final Thoughts: The stock had been up 19% since early June. AbbVie reports earnings on July 31.

Crinetics Pharmaceuticals $CRNX ( ▼ 0.47% ) surged 99.88% (wow!) in after-hours trading on Monday after Vertex Pharmaceuticals $VRTX ( ▲ 0.29% ) announced plans to acquire it for $10 billion.

Final Thoughts: Vertex fell 2% in after-hours trading, although the stock is up 17% this year.

WIP: Bitcoin's U.S. reserve still a work-in-progress as federal agencies hash it out (CoinDesk)

Surviving: Bitcoin recovers from Strategy's BTC sale, funding rates hit 9%: Are bulls back? (Cointelegraph)

Game Over: Microsoft cuts 4,800 jobs, as Xbox unit downsizes and plans to spin off four gaming studios (CNBC)

Bigger in Texas: Toyota to Shift Production of Truck From Mexico Plant to Texas (Bloomberg)

Big Profit Jump: AI chip boom lifts Samsung profits by 1,800% (BBC)

Forward to a friend and tell them to sign up here.

Pick winning stocks: Upgrade to Early Bird Prime.

Become a smarter investor: Get Early Bird Exclusives

Want more investing tips? Listen to the podcast.

Show Your Support: Buy Me a Coffee.

Questions or comments? Hit reply to reach out.

_{The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.}